Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study
Intravitreal faricimab demonstrated favourable efficacy, safety, and durability outcomes in a real-world cohort of treatment-naïve nAMD patients.
Authors
- A. Paris (ORCID: https://orcid.org/0000-0002-2908-3802)
- Moreno Menghini (ORCID: https://orcid.org/0000-0002-1432-2524)
- Giulio Volpe (ORCID: https://orcid.org/0000-0002-3891-2297)
- Michele Clerici
- Gabriela Grimaldi (ORCID: https://orcid.org/0000-0003-2435-7867)
- Giuseppe Cancian (ORCID: https://orcid.org/0000-0002-9497-3166)
Institutions
- Laboratory for Biomedical Neurosciences (CH)
- Ente Ospedaliero Cantonale (CH)
Publication Details
- Journal
- International Journal of Retina and Vitreous
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1186/s40942-024-00586-w
- Citations
- 10
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.39